A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

BACKGROUND: Complicated skin and skin structure infections (cSSSIs) frequently result in hospitalization with significant morbidity and mortality. METHODS: In this phase 3b/4 parallel, randomized, open-label, comparative study, 531 subjects with cSSSI received tigecycline (100 mg initial dose, then...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, Peter, Alpert, Marc, Rahav, Galia, Rill, Denise, Zito, Edward, Gardiner, David, Pedersen, Ron, Babinchak, Timothy, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560230/
https://www.ncbi.nlm.nih.gov/pubmed/23145952
http://dx.doi.org/10.1186/1471-2334-12-297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560230/
https://www.ncbi.nlm.nih.gov/pubmed/23145952
http://dx.doi.org/10.1186/1471-2334-12-297

Ejemplares similares